ArticleCancers2022

Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer.

Kamya Sankar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.